Cheney blasts device tax as one of 'the dumbest ideas' ever; Aurora Spine wins 510(k);

@FierceMedDev: That didn't take long: Myriad Genetics targets LabCorp with BRCA patent suit. Item | Follow @FierceMedDev

@MarkHFierce: DioGenix pulled in $3.2M in private financing to fuel continued work on its MS diagnostic test. Release | Follow @MarkHFierce

@MichaelGFierce: BioDelivery Sciences is moving ahead on its #diabetes pain gel with the FDA's blessing. Story | Follow @MichaelGFierce

@GalenMoore: Medtronic's new version of Symplicity gets a green light in EU and Australia. Release | Follow @GalenMoore

> DioGenix pulled in $3.2 million in a new private financing designed to fund an ongoing clinical trial of its new multiple sclerosis diagnostic. Item

> Former U.S. Vice President Dick Cheney termed the medical device tax as one of "the dumbest ideas" he has ever heard. Story

> California's Aurora Spine nailed down a 510(k) clearance for a new spinal fixation device for spinal fusion procedures. Item

> BSD Medical ($BSDM) said it has started selling its microwave ablation systems in Turkey, via a distributor. Item

> KUOW details how a recalled drug infuser made by the German company B. Braun malfunctioned and killed an ailing Seattle jazz musician. Story

Biotech News

@FierceBiotech: I-SPY a controversy over Puma's positive PhII test of neratini. Story | Follow @FierceBiotech

@JohnCFierce: My favorite dysfunctional pharma company, Eli Lilly, reports yet another PhIII flop. Release | Follow @JohnCFierce

@DamianFierce: If Transcept can't find a buyer, it's going to liquidate come Q2. Release | Follow @DamianFierce

@EmilyMFierce: Cellular Dynamics and Jain Foundation partner on stem cell models for muscular dystrophy. News | Follow @EmilyMFierce

> Lilly extends its streak of PhIII failures, scraps another program. More

> PaxVax snags $22M to get fast-tracked cholera pill through Phase III. Story

> FDA questions safety of Takeda's blockbuster-hopeful bowel disease drug. Article

Pharma News

@FiercePharma: GSK fends off wrongful death case alleging Paxil led to abortion. News | Follow @FiercePharma

@EricPFierce: Mylan intends to launch 800 injectable products in next 5 years--150 in U.S.--now that it owns Agila. Story | Follow @EricPFierce

@CarlyHFierce: SEC: Provenge critic lied about her bets Dendreon stock would fall. Yesterday's story | Follow @CarlyHFierce

> Sanofi's MS drug Lemtrada tripped up again, this time in U.K. More

> Pfizer fights Hanmi in Korea over its Viagra design. Story

Vaccines News

> The argument for vaccinating: 100M cases of disease prevented in U.S. Story

> Nonprofit crowdfunding tech-enabled HIV vaccine project. Piece

> Whooping cough vaccine fails to stop spread of disease in FDA animal study. More

> TB vaccine shows promise in preventing MS. News

> CDC considers expanding use of Bexsero as meningitis outbreak spreads. Article

> PaxVax raises $22M for PhIII trial of cholera vaccine. Item

Pharma Manufacturing News

> In cancer immunotherapy joint venture, Fred Hutch and MSKCC face manufacturing challenges. Piece

> Pfizer whacking 150 jobs in closure of Irish packaging plant. News

> FDA warning letter tasks Wockhardt with global plant assessment. More

> PhRMA begins another lawsuit against a drug-disposal law. Story

> Boehringer taps BofA to talk up potential of sterile injectables plant. Article

> Patheon invests in U.K. plant, posts operating loss. Item

Suggested Articles

Akoya Biosciences raised $50 million to help boost its commercialization in research, drug development and clinical testing markets.

The dream of a comfortable, tabletop blood testing device, needing only a few drops taken from a finger and a handful of minutes, has now arrived.

Novartis is now teaming up with Amazon’s mammoth cloud computing division to overhaul its manufacturing, supply and business operations.